Please assess the completion status of the following clinical trial:

Trial Title: Biomarker Identification for Bladder Cancer Patients

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: COHORT
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Adult patients ≥18 years old.~* Patients suspected, clinically diagnosed, or histologically diagnosed bladder cancer.~* Patients undergoing cystoscopy without cancer suspicion.~* Ability to give an informed consent.~Exclusion Criteria:~* Patients receiving concurrent therapy for a second malignancy.~* \< 18 years old.~* Inability to give an informed consent.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Bladder Cancer Patients (Type: None): Patients with muscle invasive bladder cancer. A sample collection of donated cancer and normal adjacent tissues, blood and urine which will be prospectively obtained from patients through the Tissue Procurement Shared Resources (TPSR) and The Ohio State University Comprehensive Cancer Center Biospecimen and Biorepository Resource (BBR) as needed.

Based on this trial design, predict the completion outcome and termination type (if applicable).